 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News Roche Says to Pull Older HIV Drug on Poor DemandMay 19, 2005 On Wednesday, Swiss drug maker Roche Holding AG said it will voluntarily discontinue its HIV drug Fortovase because of declining demand for the medicine. Due to the availability of Invirase -- a new formulation of the drug, which is better tolerated -- Roche will stop selling Fortovase in the first quarter of 2006. The decision was not based on concerns about the safety or efficacy of Fortovase, Roche said. Reuters 05.18.2005  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
